NCT00620022 - The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Indacaterol 300 μg

Indacaterol was supplied in powder filled capsules together with a single dose dry powder inhaler (SDDPI) device.

DRUG

Placebo

Placebo was supplied in powder filled capsules together with a single dose dry powder inhaler (SDDPI) device.

Trial Locations (20)

Novartis Investigator Site, Torrance

Novartis Investigator Site, Lebanon

Novartis Investigator Site, Brussels

Novartis Investigator Site, Gembloux

Novartis Investigator Site, Jette

Novartis Investigator Site, Liège

Novartis Investigator Site, Edmonton

Novartis Investigator Site, Kingston

Novartis Investigator Site, Aarhus

Novartis Investigative Site, Hellerup

Novartis Investigator Site, Hvidovre

Novartis Investigative site, Odense

Novartis Investigator Site, Genova

Novartis Investigator Site, Pisa

Novartis Investigator Site, Verona

Novartis Investigator Site, Alicante

Novartis Investigator Site, Barcelona

Novartis Investigative Site, Madrid

Novartis Investigative site, Seville

Novartis Investigator Site, Zaragoza